Publications

Year of Publicationsort descending Title Faculty Association
2008 Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2008 Progesterone receptors: form and function in brain. Roberta Diaz Brinton, Ph.D
2008 Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2008 Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Roberta Diaz Brinton, Ph.D
2008 The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Roberta Diaz Brinton, Ph.D
2008 Different mutant/wild-type p53 combinations cause a spectrum of increased invasive potential in nonmalignant immortalized human mammary epithelial cells.
2008 Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. Roberta Diaz Brinton, Ph.D
2008 Estrogen regulation of glucose metabolism and mitochondrial function: therapeutic implications for prevention of Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2008 DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage.
2008 Estrogen and hippocampal plasticity in rodent models. Roberta Diaz Brinton, Ph.D
2009 Expression of bile acid transporting proteins in Barrett's esophagus and esophageal adenocarcinoma.
2009 Occludin oligomeric assemblies at tight junctions of the blood-brain barrier are altered by hypoxia and reoxygenation stress. Jeffrey J. Lochhead, PhD
2009 Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Roberta Diaz Brinton, Ph.D
2009 Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2009 Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Roberta Diaz Brinton, Ph.D
2009 Novel bifunctional peptides as opioid agonists and NK-1 antagonists. Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD
2009 Progesterone increases rat neural progenitor cell cycle gene expression and proliferation via extracellularly regulated kinase and progesterone receptor membrane components 1 and 2. Roberta Diaz Brinton, Ph.D
2010 Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy. Roberta Diaz Brinton, Ph.D
2010 Sustained morphine-mediated pain sensitization and antinociceptive tolerance are blocked by intrathecal treatment with Raf-1-selective siRNA. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2010 MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. John M. Streicher, PhD
2010 Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2010 Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2. John M. Streicher, PhD
2010 Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Roberta Diaz Brinton, Ph.D
2010 Recently patented and promising ORL-1 ligands: where have we been and where are we going? Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2010 Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. Thomas P Davis, PhD, Jeffrey J. Lochhead, PhD

Pages